Kok Fei Chan

Company: Olivia Newton-John Cancer Research Institute

Job title: Research Fellow

Seminars:

Virtual Talk: Characterizing Human Vδ1+ and Vδ2+ γδ T Cells to Advance Tumor Immunotherapy Development 1:30 pm

Understanding the role of TCR vs NK2G receptors in mediating cytotoxic function to identify the most efficacious checkpoint therapy Harnessing the synergy or negative regulation of receptor signalling between subsets to maximize therapeutic potential Assessing the impact of TCR selectivity due to HLA matching to prevent the patient pool from narrowingRead more

day: Conference Day Two - Afternoon Track A